Aurinia Pharmaceuticals Stock Price History

AUPH Stock  USD 5.03  0.03  0.60%   
Below is the normalized historical share price chart for Aurinia Pharmaceuticals extending back to July 16, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aurinia Pharmaceuticals stands at 5.03, as last reported on the 28th of March, with the highest price reaching 5.03 and the lowest price hitting 5.03 during the day.
IPO Date
26th of January 1999
200 Day MA
8.4112
50 Day MA
6.5504
Beta
1.377
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Aurinia Stock, it is important to understand the factors that can impact its price. Aurinia Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.2, which signifies that the company had a -0.2% return per unit of risk over the last 3 months. Aurinia Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aurinia Pharmaceuticals' Mean Deviation of 2.44, risk adjusted performance of (0.1), and Standard Deviation of 4.1 to double-check the risk estimate we provide.
  
As of now, Aurinia Pharmaceuticals' Common Stock Total Equity is increasing as compared to previous years. The Aurinia Pharmaceuticals' current Common Stock is estimated to increase to about 1.3 B, while Other Stockholder Equity is projected to decrease to under 66.4 M. . As of now, Aurinia Pharmaceuticals' Price Fair Value is increasing as compared to previous years. Aurinia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsAUPH

Estimated Market Risk

 4.19
  actual daily
36
64% of assets are more volatile

Expected Return

 -0.84
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.2
  actual daily
0
Most of other assets perform better
Based on monthly moving average Aurinia Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aurinia Pharmaceuticals by adding Aurinia Pharmaceuticals to a well-diversified portfolio.
Price Book
1.8864
Enterprise Value Ebitda
(7.30)
Price Sales
4.1157
Shares Float
131.7 M
Wall Street Target Price
11.29

Aurinia Pharmaceuticals Stock Price History Chart

There are several ways to analyze Aurinia Stock price data. The simplest method is using a basic Aurinia candlestick price chart, which shows Aurinia Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 8, 20249.31
Lowest PriceMarch 26, 20244.93

Aurinia Pharmaceuticals March 28, 2024 Stock Price Synopsis

Various analyses of Aurinia Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aurinia Stock. It can be used to describe the percentage change in the price of Aurinia Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aurinia Stock.
Aurinia Pharmaceuticals Price Rate Of Daily Change 1.01 
Aurinia Pharmaceuticals Price Action Indicator 0.02 

Aurinia Pharmaceuticals March 28, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Aurinia Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Aurinia Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Aurinia Stock and then apply it to test your longer-term investment strategies against Aurinia.

Aurinia Stock Price History Data

The price series of Aurinia Pharmaceuticals for the period between Fri, Dec 29, 2023 and Thu, Mar 28, 2024 has a statistical range of 4.39 with a coefficient of variation of 20.75. The prices are distributed with arithmetic mean of 7.09. The median price for the last 90 days is 7.74. The company had 1:50 stock split on 23rd of October 2013.
OpenHighLowCloseVolume
03/28/2024
 5.00  5.03  5.03  5.03 
03/27/2024 4.95  5.01  4.85  5.00  1,437,585 
03/26/2024 4.98  5.07  4.93  4.93  948,637 
03/25/2024 5.00  5.07  4.96  4.99  969,029 
03/22/2024 5.03  5.03  4.94  4.97  1,792,304 
03/21/2024 5.20  5.25  5.00  5.01  1,871,073 
03/20/2024 5.15  5.23  5.03  5.14  1,790,839 
03/19/2024 5.05  5.19  4.96  5.18  1,176,515 
03/18/2024 5.18  5.22  5.06  5.09  1,267,080 
03/15/2024 5.07  5.20  5.06  5.17  2,205,079 
03/14/2024 5.20  5.24  4.98  5.09  1,987,498 
03/13/2024 5.16  5.29  5.16  5.25  1,344,705 
03/12/2024 5.39  5.39  5.19  5.20  1,874,071 
03/11/2024 5.40  5.56  5.35  5.37  1,469,156 
03/08/2024 5.46  5.63  5.40  5.43  1,353,113 
03/07/2024 5.51  5.58  5.39  5.45  1,342,221 
03/06/2024 5.66  5.67  5.48  5.52  1,747,423 
03/05/2024 5.72  5.79  5.56  5.60  2,042,420 
03/04/2024 5.78  5.80  5.61  5.76  1,754,585 
03/01/2024 5.73  5.88  5.64  5.78  1,582,094 
02/29/2024 5.96  6.02  5.72  5.72  2,040,946 
02/28/2024 5.95  6.03  5.76  5.84  2,352,079 
02/27/2024 6.04  6.12  5.88  6.02  2,168,470 
02/26/2024 5.90  6.10  5.89  6.00  2,561,419 
02/23/2024 5.96  6.13  5.90  5.95  2,666,577 
02/22/2024 5.70  6.02  5.64  6.00  4,163,264 
02/21/2024 5.55  5.80  5.35  5.74  5,582,866 
02/20/2024 5.75  5.85  5.52  5.59  4,774,510 
02/16/2024 5.92  6.13  5.67  5.85  5,598,888 
02/15/2024 6.00  6.20  5.50  6.02  19,621,088 
02/14/2024 7.94  7.98  7.67  7.97  2,810,670 
02/13/2024 8.00  8.13  7.74  7.78  2,246,364 
02/12/2024 8.28  8.50  8.22  8.32  2,422,593 
02/09/2024 7.98  8.35  7.92  8.29  2,772,832 
02/08/2024 7.78  7.95  7.71  7.91  1,073,941 
02/07/2024 7.90  7.90  7.71  7.78  985,931 
02/06/2024 7.51  7.95  7.50  7.93  1,447,377 
02/05/2024 7.57  7.66  7.49  7.55  1,091,945 
02/02/2024 7.62  7.73  7.46  7.68  1,551,910 
02/01/2024 7.62  7.84  7.41  7.73  1,610,426 
01/31/2024 7.72  7.91  7.53  7.54  1,624,990 
01/30/2024 7.98  7.99  7.72  7.74  1,130,825 
01/29/2024 8.00  8.06  7.78  8.03  1,141,025 
01/26/2024 8.09  8.13  7.91  7.99  1,067,211 
01/25/2024 7.98  8.04  7.80  8.04  1,123,120 
01/24/2024 8.15  8.22  7.87  7.88  1,615,830 
01/23/2024 8.18  8.24  7.92  8.05  1,442,932 
01/22/2024 7.97  8.30  7.91  8.10  2,094,917 
01/19/2024 7.93  8.05  7.80  8.00  1,648,040 
01/18/2024 7.90  8.00  7.71  7.88  2,616,993 
01/17/2024 7.70  7.91  7.53  7.87  1,490,098 
01/16/2024 7.70  8.10  7.56  7.80  3,208,085 
01/12/2024 8.00  8.11  7.64  7.74  2,851,420 
01/11/2024 8.40  8.43  7.77  7.92  4,733,843 
01/10/2024 9.13  9.43  8.46  8.51  2,857,573 
01/09/2024 9.18  9.33  8.88  8.99  2,250,298 
01/08/2024 8.35  9.31  8.21  9.31  3,703,945 
01/05/2024 8.44  8.82  8.20  8.40  4,842,031 
01/04/2024 8.46  8.60  8.18  8.21  1,719,668 
01/03/2024 8.67  8.70  8.39  8.45  1,206,193 
01/02/2024 8.86  8.98  8.65  8.74  1,410,695 

About Aurinia Pharmaceuticals Stock history

Aurinia Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aurinia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aurinia Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aurinia Pharmaceuticals stock prices may prove useful in developing a viable investing in Aurinia Pharmaceuticals
Last ReportedProjected for 2024
Common Stock Shares Outstanding143.2 M150.4 M
Net Loss-97.4 M-92.5 M

Aurinia Pharmaceuticals Quarterly Net Working Capital

347.61 Million

Aurinia Pharmaceuticals Stock Technical Analysis

Aurinia Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Aurinia Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aurinia Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Aurinia Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Aurinia Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Aurinia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aurinia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Aurinia Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurinia Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurinia Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurinia Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurinia Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Aurinia Stock analysis

When running Aurinia Pharmaceuticals' price analysis, check to measure Aurinia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurinia Pharmaceuticals is operating at the current time. Most of Aurinia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aurinia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurinia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aurinia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Is Aurinia Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurinia Pharmaceuticals. If investors know Aurinia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurinia Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Revenue Per Share
1.225
Quarterly Revenue Growth
0.586
Return On Assets
(0.11)
Return On Equity
(0.20)
The market value of Aurinia Pharmaceuticals is measured differently than its book value, which is the value of Aurinia that is recorded on the company's balance sheet. Investors also form their own opinion of Aurinia Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aurinia Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurinia Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aurinia Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aurinia Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurinia Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurinia Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.